Congress
MapWatchScheduleDaily RecordMembersCommitteesLegislationNominations
Money & Oversight
MoneyOffice SpendingSubpoenasHouse EthicsForeign InfluenceSpecial Rules
Executive & Law
AgenciesRegulationsUS Code

Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Search⌘K
Congress
MapWatchScheduleDaily RecordMembersCommitteesLegislationNominations
Money & Oversight
MoneyOffice SpendingSubpoenasHouse EthicsForeign InfluenceSpecial Rules
Executive & Law
AgenciesRegulationsUS Code

Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034
rulemaking dockets
4,738
open for public comment
You can weigh in on these right now
Source: Regulations.gov.

Showing 30 of 13,034 dockets

Nonrulemaking
FDA

FDA-2023-E-3308

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 10,314,694

7 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-1642

DAB Civil Money Penalty; Supernova Smoke LLC d/b/a Super Nova; CLOSED 4/21/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2023-E-3307

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,820,851

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3306

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,693,859

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3305

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,681,949

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3304

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,545,307

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3303

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,351,828

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3302

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,289,296

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3298

Patent Term Extension Application for NAVITOR Transcatheter Aortic Valve Implantation System, Patent No. 9,220,594

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3264

Patent Term Extension Application for BRIUMVI® (ublituximab-xiiy), Patent No. 9,873,745

7 docsNo comments
Nonrulemaking
FDA

FDA-2023-E-3263

Patent Term Extension Application for BRIUMVI (ublituximab-xiiy), Patent No. 9,234,045

7 docsNo comments
Nonrulemaking
FDA

FDA-2022-E-2246

Patent Term Extension Application for WINLEVI® (clascoterone) US Patent No.10,159,682

6 docsNo comments
Rulemaking
OCC

OCC-2025-0273

OCC Eases Licensing Rules for Small National Banks and Savings Associations

2 docs8 comments
Nonrulemaking
FDA

FDA-2026-H-2133

DAB Civil Money Penalty; A1 Minimarket and Deli Corp d/b/a A1-Minimarket; CLOSED 4/21/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-2146

DAB Civil Money Penalty; Almosawi LLC, d/b/a Pops C Store; CLOSED 4/21/2026

1 docNo comments
Nonrulemaking
DARS

DARS-2025-0006

Defense Department Seeks Comments on New Cyber Incident and Cloud Reporting Rules for Contractors

2 docs1 comment
Nonrulemaking
FDA

FDA-2026-H-4176

DAB Civil Money Penalty; Western Sky Food Mart LLC d/b/a Express Tobacco & Vape

1 docNo comments
Nonrulemaking
FDA

FDA-2022-E-2244

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. 9,486,458

6 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-4175

DAB Civil Money Penalty; Thomas Schuh d/b/a Tom’s Drive Thru

1 docNo comments
Nonrulemaking
FDA

FDA-2022-E-2243

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 9,433,628

6 docsNo comments
Nonrulemaking
FDA

FDA-2022-E-2208

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 9,211,295

7 docsNo comments
Nonrulemaking
FDA

FDA-2022-E-2207

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 8,865,690

7 docsNo comments
Nonrulemaking
FDA

FDA-2022-E-2206

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 8,785,427

6 docsNo comments
Nonrulemaking
FDA

FDA-2022-E-2205

Patent Term Extension Application for WINLEVI® (clascoterone), U.S. Patent No. 8,143,240

7 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-7127

Patent Term Application for PALSONIFY (paltusotine), Patent No. 10,875,839

3 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-7125

Patent Term Application for PALSONIFY (paltusotine), Patent No. 10,597,377

3 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-7124

Patent Term Application for PALSONIFY (paltusotine), Patent No. 10,464,918

3 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-7123

Patent Term Application for PALSONIFY (paltusotine), Patent No. 9,896,432

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-1008

Patent Term Extension Application for KOMZIFTI (ziftomenib), Patent No. 10,781,218

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-E-1007

Patent Term Extension Application for KOMZIFTI (ziftomenib), Patent No. 10,077,271

3 docsNo comments
  • Previous
  • Page 280 of 435
  • Next